Literature DB >> 11155324

Chromatin packaging as an indicator of human sperm dysfunction.

A D Esterhuizen1, D R Franken, J G Lourens, C Van Zyl, I I Müller, L H Van Rooyen.   

Abstract

PURPOSE: Understanding the causes of fertilization failure is an important research field in assisted reproductive programs. The present study aimed to evaluated the possible relationship between chromatin packaging quality (CMA3 staining) and (i) normal morphology and (ii) its ability to predict the functional integrity of spermatozoa in both in vitro fertilization (IVF) and intracytoplasmic sperm injection (ICSI) treatment programs.
METHODS: Semen of 140 men from IVF and ICSI couples were analyzed for sperm concentration, motility, morphology, and chromatin packaging (CMA3). For CMA3 classification, two cutoff values were used, namely, 44.5% +/- 13 and 1 SD above the mean, i.e., 57.5% (rounded off to 60%). IVF and ICSI data were stratified using three basic cutoff values for CMA3 staining, namely, < 44%, > 44-60%, and > 60%.
RESULTS: Based on CMA3 results patients were divided into four groups, namely, group A, < 44% CMA3 (n = 15, IVF); group B, > or = 44% and < 60% CMA3 (n = 39, IVF); group C, > or = 60% CMA3 (n = 45 IVF); and group D, > or = 60% CMA3 (n = 41 ICSI). During receiver operator characteristic analyses the estimated cutoff value for CMA3 staining, to distinguish between < 4% and > or = 4% morphology groups, was 60%. The area under the curve was 0.89, sensitivity of 75%, and specificity of 100%. When IVF rates of > 60% and < 60% were used, the optimal CMA3 value for prediction of fertilization success again was recorded at 60%. The area under the curve was 0.76, sensitivity of 81.5%, and specificity of 63.6%.
CONCLUSIONS: Chromatin packaging assessments should be included as a complementary assay to the sequential diagnostic approach of the male-factor patients.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11155324      PMCID: PMC3455265          DOI: 10.1023/a:1009493824953

Source DB:  PubMed          Journal:  J Assist Reprod Genet        ISSN: 1058-0468            Impact factor:   3.412


  19 in total

Review 1.  Cell and molecular biological challenges of ICSI: ART before science?

Authors:  G Schatten; L Hewitson; C Simerly; P Sutovsky; G Huszar
Journal:  J Law Med Ethics       Date:  1998       Impact factor: 1.718

2.  Utility of the sperm chromatin structure assay as a diagnostic and prognostic tool in the human fertility clinic.

Authors:  D P Evenson; L K Jost; D Marshall; M J Zinaman; E Clegg; K Purvis; P de Angelis; O P Claussen
Journal:  Hum Reprod       Date:  1999-04       Impact factor: 6.918

3.  Infertility in intracytoplasmic-sperm-injection-derived sons.

Authors:  M G Kent-First; S Kol; A Muallem; S Blazer; J Itskovitz-Eldor
Journal:  Lancet       Date:  1996-08-03       Impact factor: 79.321

4.  Mitotic chromosomal anomalies among 1210 infertile men.

Authors:  N Pandiyan; A M Jequier
Journal:  Hum Reprod       Date:  1996-12       Impact factor: 6.918

5.  Diagnostic tests 3: receiver operating characteristic plots.

Authors:  D G Altman; J M Bland
Journal:  BMJ       Date:  1994-07-16

6.  Chromatin packaging and morphology in ejaculated human spermatozoa: evidence of hidden anomalies in normal spermatozoa.

Authors:  P G Bianchi; G C Manicardi; F Urner; A Campana; D Sakkas
Journal:  Mol Hum Reprod       Date:  1996-03       Impact factor: 4.025

Review 7.  Consensus workshop on advanced diagnostic andrology techniques. ESHRE (European Society of Human Reproduction and Embryology) Andrology Special Interest Group.

Authors: 
Journal:  Hum Reprod       Date:  1996-07       Impact factor: 6.918

8.  Presence of endogenous nicks in DNA of ejaculated human spermatozoa and its relationship to chromomycin A3 accessibility.

Authors:  G C Manicardi; P G Bianchi; S Pantano; P Azzoni; D Bizzaro; U Bianchi; D Sakkas
Journal:  Biol Reprod       Date:  1995-04       Impact factor: 4.285

9.  The use of epididymal and testicular spermatozoa for intracytoplasmic sperm injection: the genetic implications for male infertility.

Authors:  S J Silber; Z Nagy; J Liu; H Tournaye; W Lissens; C Ferec; I Liebaers; P Devroey; A C Van Steirteghem
Journal:  Hum Reprod       Date:  1995-08       Impact factor: 6.918

10.  High fertilization and pregnancy rate after intracytoplasmic sperm injection with spermatozoa obtained from testicle biopsy.

Authors:  S J Silber; A C Van Steirteghem; J Liu; Z Nagy; H Tournaye; P Devroey
Journal:  Hum Reprod       Date:  1995-01       Impact factor: 6.918

View more
  6 in total

1.  Cytogenetic analysis of sperm nucleous components of iranian normal and sub-fertile individuals using zona free hamster oocytes.

Authors:  H Mozdarani; A Mohseni Meybodi
Journal:  J Assist Reprod Genet       Date:  2004-11       Impact factor: 3.412

2.  The effect of ambient air pollution on sperm quality.

Authors:  Craig Hansen; Thomas J Luben; Jason D Sacks; Andrew Olshan; Susan Jeffay; Lillian Strader; Sally D Perreault
Journal:  Environ Health Perspect       Date:  2010-02       Impact factor: 9.031

3.  The healthy men study: an evaluation of exposure to disinfection by-products in tap water and sperm quality.

Authors:  Thomas J Luben; Andrew F Olshan; Amy H Herring; Susan Jeffay; Lillian Strader; Rebecca M Buus; Ronna L Chan; David A Savitz; Philip C Singer; Howard S Weinberg; Sally D Perreault
Journal:  Environ Health Perspect       Date:  2007-08       Impact factor: 9.031

4.  Impact of sperm chromatin evaluation on fertilization rate in intracytoplasmic sperm injection.

Authors:  Farhad Golshan Iranpour
Journal:  Adv Biomed Res       Date:  2014-11-29

5.  Mobile phone radiation induces reactive oxygen species production and DNA damage in human spermatozoa in vitro.

Authors:  Geoffry N De Iuliis; Rhiannon J Newey; Bruce V King; R John Aitken
Journal:  PLoS One       Date:  2009-07-31       Impact factor: 3.240

6.  Assessment of chromatin maturity in human spermatozoa: useful aniline blue assay for routine diagnosis of male infertility.

Authors:  Afifa Sellami; Nozha Chakroun; Soumaya Ben Zarrouk; Hanen Sellami; Sahbi Kebaili; Tarek Rebai; Leila Keskes
Journal:  Adv Urol       Date:  2013-10-03
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.